Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli

Bioprocess and Biosystems Engineering
Suman MazumdarSyed Shams Yazdani

Abstract

The C-terminal, 19-kDa domain of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) is among the leading vaccine candidate for malaria due to its essential role in erythrocyte invasion by the parasite. We designed a synthetic gene for optimal expression of recombinant PfMSP-1(19) in Escherichia coli and developed a scalable process to obtain high-quality PfMSP-1(19). The synthetic gene construct yielded a fourfold higher expression level of PfMSP-1(19) in comparison to the native gene construct. Optimization of cultivation conditions in the bioreactor indicated important role of yeast extract and substrate feeding strategy for obtaining enhanced expression of soluble and correctly folded PfMSP-1(19). It was observed that the higher expression level of PfMSP-1(19) was essentially associated with the generation of higher level of incorrectly folded PfMSP-1(19). A simple purification procedure comprising metal affinity and ion exchange chromatography was developed to purify correctly folded form of PfMSP-1(19) from cell lysate. Biochemical and biophysical characterization of purified PfMSP-1(19) suggested that it was highly pure, homogeneous, and correctly folded.

References

Feb 1, 1994·Parasite Immunology·I T LingA A Holder
Feb 8, 2002·Nature·Thomas L Richie, Allan Saul
Oct 9, 2002·Nature·Malcolm J GardnerBart Barrell
Jan 1, 1994·Parasitology Today·A A Holder, M J Blackman
Dec 21, 2004·Journal of Biotechnology·Hans Peter Sørensen, Kim Kusk Mortensen
Jan 27, 2005·Biotechnology Letters·Syed Shams YazdaniChetan E Chitnis
Mar 7, 2006·Current Molecular Medicine·S S YazdaniC E Chitnis
Feb 26, 2008·Bulletin of the World Health Organization
Dec 10, 2008·The New England Journal of Medicine·Philip BejonLorenz von Seidlein
May 7, 2009·Immunology and Cell Biology·Jack S Richards, James G Beeson

❮ Previous
Next ❯

Citations

Mar 2, 2013·The Journal of Infectious Diseases·Alfredo MayorChetan E Chitnis
May 3, 2014·Clinical and Vaccine Immunology : CVI·Puneet K GuptaVirander S Chauhan
Aug 20, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pilar RequenaCarlota Dobaño
Feb 11, 2021·Molecular Biotechnology·Yvonne Jing Mei LiewBoon Chin Tan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.